Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gilberto de Castro, Jr., MD, PhD"'
Autor:
Vladmir C. Cordeiro de Lima, MD, PhD, Ana Gelatti, MD, MSc, José F.P. Moura, MD, PhD, Aline F. Fares, MD, MSc, Gilberto de Castro, Jr., MD, PhD, Clarissa Mathias, MD, PhD, Ricardo M. Terra, MD, PhD, Gustavo Werutsky, MD, PhD, Marcelo Corassa, MD, Luiz Henrique L. Araújo, MD, PhD, Eduardo Cronenberger, MD, MSc, Fernanda K. Fujiki, MD, Sandro Reichow, MD, Antônio Vinícius T. da Silva, MD, Tércia V. Reis, MD, Mônica Luciana A. Padoan, MD, Patrícia Pacheco, MD, Rosely Yamamura, MD, Caroline Kawamura, MD, Eldsamira Mascarenhas, MD, MSc, Rafaela G. de Jesus, MSc, Gustavo Gössling, MD, Clarissa Baldotto, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 3, Pp 100646- (2024)
Introduction: Stage III NSCLC is a heterogeneous disease, representing approximately one-third of newly diagnosed lung cancers. Brazil lacks detailed information regarding stage distribution, treatment patterns, survival, and prognostic variables in
Externí odkaz:
https://doaj.org/article/c85f0e6d994f4d829843e70ea47ec0c1
Autor:
Gilberto de Castro, Jr., MD, PhD, Fabiano Hahn Souza, MD, PhD, Júlia Lima, MSc, Luis Pedro Bernardi, BBS, Carlos Henrique Andrade Teixeira, MD, Gustavo Faibischew Prado, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100580- (2023)
Introduction: The implementation of multidisciplinary teams (MDTs) has been found to be effective for improving outcomes in oncology. Nevertheless, there is still a dearth of robust literature on patients with NSCLC. The aim of this study was to cond
Externí odkaz:
https://doaj.org/article/2279f39658414d41854b7a45593dd5cf
Autor:
Aline F. Fares, MD, MSc, Pedro H. Martinez, Pedro H. Farina, Isaac Bicalho de Souza, Daniel V. Araújo, MD, Narayana S. Paiva, Ligia F. Orlando, Tatiana Elias Colombo, PhD, Eldsamira Mascarenhas, MD, MSc, Ana Caroline Z. Gelatti, MD, MSc, Clarissa Baldotto, MD, PhD, Mauro Zukin, MD, PhD, Luiz Henrique Araujo, MD, PhD, Clarissa Mathias, MD, PhD, Gustavo Werutsky, MD, PhD, Gilberto de Castro, Jr., MD, PhD, Vladmir C. Cordeiro de Lima, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 10, Pp 100402- (2022)
Introduction: Advances in comprehensive genomic profiling (CGP) of lung adenocarcinomas (LUADs) led to personalized treatment for patients. This study evaluated medical oncologists’ attitudes toward CGP in a scenario where sponsored funding for CGP
Externí odkaz:
https://doaj.org/article/982213cea12049148c048f554f92da99
Autor:
Aaron S. Mansfield, MD, Roy S. Herbst, MD, PhD, Gilberto de Castro, Jr., MD, PhD, Rina Hui, MB, BS, PhD, Nir Peled, MD, PhD, Dong-Wan Kim, MD, Silvia Novello, MD, PhD, Miyako Satouchi, MD, Yi-Long Wu, MD, Edward B. Garon, MD, Martin Reck, MD, PhD, Andrew G. Robinson, MD, Ayman Samkari, MD, Bilal Piperdi, MD, Victoria Ebiana, MD, Jianxin Lin, MS, Tony S.K. Mok, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100205- (2021)
Introduction: We retrospectively evaluated outcomes in patients with programmed death-ligand 1 (PD-L1)–positive non–small-cell lung cancer (NSCLC) to determine whether baseline (i.e., at study enrollment) brain metastases were associated with the
Externí odkaz:
https://doaj.org/article/4253c840bb3a4ea2a990a5ad8dd55f52